The CTN – An innovative partnership

The CIHR Canadian HIV Trials Network (CTN) is an innovative partnership of clinical investigators, physicians, nurses, people living with HIV, pharmaceutical manufacturers and others that facilitate HIV clinical trials of the highest scientific and ethical standards.

Established in 1990 as a cornerstone of the federal AIDS Strategy, the CTN is funded by the Canadian Institutes of Health Research (CIHR), and jointly sponsored by the University of British Columbia and St. Paul’s Hospital (Providence Health Care) in Vancouver.

Over 300 trials reviewed

Implemented 170 trials of HIV therapies

Over 10,000 participants

Funded 136 CTN Postdoctoral Fellowships

Mission

The CTN is a Canada-wide partnership of researchers, caregivers, governments, health advocates, the innovative pharmaceutical and biotechnology industry, and people living with HIV who are committed to developing treatments, preventions and a cure for HIV and related health conditions, through the conduct of scientifically sound and ethical trials. The CTN is committed to maximizing the impact of research and ultimately improving the health of Canadians by applying knowledge gained through research at home and abroad into applications and practice.

Vision

The CTN continues to facilitate high-quality, investigator-driven clinical trials and innovative clinical research, while engaging with knowledge-brokers and community in both official languages, and sharing resources and expertise among researchers, clinical trial sites, and institutions.

Strategic Priorities

The CTN’s vision is translated into an actionable research agenda via the activities of our Research Cores. Each Core has its own priorities, but linkages and cross-cutting themes enable our researchers to maximize their collective capacity, addressing research priorities for both the Canadian HIV population and similarly affected populations abroad.

Latest News

Guest Blog: CTN Postdoc Dr. Malika Sharma

| Uncategorized | No Comments

CTN Postdoctoral Fellow Dr. Malika Sharma writes about the current state of PrEP in Canada and how CTN 303 looks to change the way these HIV prevention drugs are delivered.

Guest Blog: My Experience Interning at the CTN, Part 1

| Uncategorized | No Comments

Hi everyone! My name is Sonia, and I’m one of the Communications and Knowledge Translation Interns working with the CTN this summer.

Marina Klein’s tribute to Mark Wainberg at IAS 2017: VIDEO + TEXT

| Uncategorized | No Comments

Read the full text of Dr. Klein’s speech below. Tribute to Mark Wainberg It’s with great sadness that I stand…

Community Engagement Resource available online

| Uncategorized | No Comments

The Resource includes sections about when to begin to include community, who to engage in the process, and how to develop roles and compensate team members.